Catalysts
PRODUCTS
-
![business-people-shaking-hands-GettyImages-908944978]( "Functional Service Provider (FSP)")
At ProPharma, we offer a unique approach to the traditional Clinical Research Organization (CRO) Full-Service Provider (FSP) model.
-
![Curebase app ePRO- feature]( "A Single Digital Experience Participants Will Love")
Experience higher data quality, retention and participant compliance by providing a truly engaging experience from data submission to reminders, appointment management, telemedicine and more -- from the phone, tablet, or desktop.
-
![pSemi - CMOS switch]( "UltraCMOS SP4T RF Switch: PE42447")
The PE42447 is an SP4T RF switch that supports a frequency range from 10 MHz to 8 GHz. It delivers extremely low insertion loss and high linearity with high input power handling.
-
![MPBR-0122CSP3]( "1 - 22 GHz MMIC 2-Way High Isolation Power Divider/Power Splitter: MPBR-0122CSP3")
The MPBR-0122CSP3 is a compact, high-performance MMIC power divider/power splitter that operates across the 1 to 22 GHz frequency range.
-
![MBAL-0250CSP2]( "2-50 GHz Passive MMIC Chip Scale Package 1:2 Balun: MBAL-0250CSP2")
The MBAL-0250CSP2 is a passive monolithic microwave integrated circuit (MMIC) 1:2 balun developed by Marki Microwave, designed to operate across an exceptionally wide frequency range of 2 to 50 GHz.
WHITE PAPERS AND CASE STUDIES
-
![GettyImages-1441771695-partnership-office-laptop-windows]( "Restarting A Manufacturing Campus And Revitalizing A Community")
Restarting A Manufacturing Campus And Revitalizing A CommunityA high‑risk facility acquisition in Huntsville became a blueprint for revitalizing a modern pharmaceutical campus. Discover how coordinated action turned a massive shutdown into a renewed manufacturing hub.
-
![GettyImages-1489414892 Technological Software Engineering Department Manager Using A Laptop]( "Outgrowing Excel: Implementing RTSM Software In A Live Phase I Trial")
Outgrowing Excel: Implementing RTSM Software In A Live Phase I TrialMoving from manual spreadsheets to RTSM mid-study requires precision. Learn how clinical teams maintain trial momentum while executing protocol changes without delays.
-
![GettyImages-1087219020 Scientists wearing protective coveralls working in manufacturing laboratory]( "Solid-State Characterization Of A Small Molecule API")
Solid-State Characterization Of A Small Molecule APIEnsuring the consistency and purity of the API is paramount when developing a new drug. Learn about the importance of CRO partnerships when facing tight deadlines and complex scientific hurdles.
-
![GettyImages-2024513353 drug manufacturing]( "Comparative Analysis Of Batch And Continuous Processes")
Comparative Analysis Of Batch And Continuous ProcessesExplore a comparative analysis that showcases the superior performance of continuous processing over traditional batch methods, highlighting key improvements in efficiency and environmental impact.
-
![GettyImages-2174865907 workflow, lab, cell therapy]( "Successful Cell-Based ADA Collaboration In mRNA Gene Replacement Therapy")
Successful Cell-Based ADA Collaboration In mRNA Gene Replacement TherapyA biotech firm developed a rapid, sensitive, cell-based ADA assay through collaborative innovation, reducing variability and turnaround time while improving performance for mRNA gene therapy.
-
![1920_img_2158 (1)]( "How Green Chemistry Initiatives Reduced Cost While Increasing Yield")
How Green Chemistry Initiatives Reduced Cost While Increasing YieldGreen process redesign improved yield, reduced waste and solvent use, and cut manufacturing costs by 30% while enabling efficient, scalable production of an oncology compound.
-
![clinical-compliance-GettyImages-2259718661]( "Urgent Compliance Recovery Following Vendor Transition")
Urgent Compliance Recovery Following Vendor TransitionRapid local leadership, clear ownership of corrective actions, and governed oversight enabled time‑critical remediation of legacy safety gaps, restoring regulatory confidence and protecting market continuity under intense inspection pressure.
-
![GettyImages-1142528978 digital healthcare]( "From Paper To Digital Study Management In Large Patient Registries")
From Paper To Digital Study Management In Large Patient RegistriesUncover how this sponsor was able to independently design and oversee its clinical study, minimizing external assistance, and easing the workload for their sites through mobile app accessibility.
-
![GettyImages-2155418067-bioreactor-scientist-ipad-beaker]( "iPSC Aggregate Culture In Bioreactors Equipped With 8-Blade Impellers")
iPSC Aggregate Culture In Bioreactors Equipped With 8-Blade ImpellersControlled aggregation, oxygen management, and scalable workflows drive consistent iPSC expansion. Parallelized systems and precise parameter control improve reproducibility for faster optimization and confident transitions.
-
![GettyImages-2181934436-laboratory-analysis-scientists-technology-computer]( "Streamline Analytical Tech Transfer Through Analytical Target Profile")
Streamline Analytical Tech Transfer Through Analytical Target ProfileAnalytics debt in CGT can derail timelines and budgets. Learn how early ATP planning and cross-functional alignment can eliminate costly setbacks and accelerate IND approvals.
-
![GettyImages-869290346 protocol]( "Delivering A Registrational GI Trial Through Ongoing Protocol Shifts")
Delivering A Registrational GI Trial Through Ongoing Protocol ShiftsA biotech developing bispecific antibodies partnered with a flexible CRO to launch its first U.S. GI oncology trial, requiring strategic insight and full-service clinical support.
-
![GettyImages-697650898_medical data]( "How Flatiron Supported The Beat AML<sup>®</sup> Master Clinical Trial")
How Flatiron Supported The Beat AML® Master Clinical TrialFind out how the Leukemia and Lymphoma Society's partnership with Flatiron Health helped improve the Beat AML® Master Clinical Trial's data management and accelerate trial timelines.
NEWS
-
Puraffinity Signs First Commercial Agreement For Full-Scale Deployment Of Its PFAS Removal Technology6/2/2025
The agreement was signed with Envytech Solutions, the leading expert in mobile water treatment in the Nordic region and a member of the Sortera Group, which operates across the Nordics and the UK.
-
Anritsu Unveils New Software-Based Solution For 5G IoT Chipset And Device Development Tests2/28/2025
Anritsu Corporation is proud to introduce the Virtual Signalling Tester NR Software MX844030PC, a software-based test simulator for developing 5G IoT chipsets and devices. The solution supports 5G IoT test by using a new simulator that operates in a virtual environment on a PC using advanced architecture, as well as a Software Defined Radio (SDR) that implements most conventional radio functions in software.
-
Quantum Biopharma Announces Signing Of An Agreement With A Global Pharmaceutical Contract Research Organization To Prepare An IND (Investigational New Drug) Application Package For Lucid-21-302 (Lucid-MS), A First-In-Class Treatment For Multiple Sclerosis5/20/2025
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces that it has signed an agreement with a global pharmaceutical contract research organization to prepare an IND (Investigational New Drug) application package for Lucid-21-302 (Lucid-MS) with the US FDA.
-
AEON Biopharma Appoints Industry Veteran Rob Bancroft As Chief Executive Officer4/21/2025
AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications, announced today the appointment of Rob Bancroft as President and Chief Executive Officer, effective April 29, 2025. Mr. Bancroft will also join AEON’s Board of Directors.
-
3-In-1 Orbital Thread Milling Cutters For New Thread Sizes1/14/2025
Following the successful introduction of the Thrill·tec TC645 Supreme orbital drill/thread mills for dimensions from M4 to M12 in 2023, Walter is now expanding its range to cover additional metric dimensions from M14 to M20 as well as their imperial equivalents.
ABOUT
Catalysts
Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy. For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.
Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.
All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present. When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.
Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst. Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.
Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature. Applications of this technology include oil and petrochemical industries.